Literature DB >> 8560433

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

J T Brandt1, D A Triplett, B Alving, I Scharrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8560433

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  141 in total

Review 1.  Testing for and clinical significance of anticardiolipin antibodies.

Authors:  S W Reddel; S A Krilis
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  How to treat women with antiphospholipid antibodies in pregnancy?

Authors:  R H Derksen; P G De Groot; H K Nieuwenhuis; G C Christiaens
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

3.  Predictors of maternal and fetal complications in SLE patients: a prospective study.

Authors:  Elisabetta Borella; Andrea Lojacono; Mariele Gatto; Laura Andreoli; Marco Taglietti; Luca Iaccarino; Edoardo Casiglia; Leonardo Punzi; Angela Tincani; Andrea Doria
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

4.  Lupus anticoagulant in immune thrombocytopenic purpura.

Authors:  Sumitra Dash; R K Marwaha; Sambit Mohanty
Journal:  Indian J Pediatr       Date:  2004-06       Impact factor: 1.967

Review 5.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

Review 6.  Impaired fibrinolysis in the antiphospholipid syndrome.

Authors:  Katie A Krone; Kristi L Allen; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

7.  Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot.

Authors:  R R Forastiero; M E Martinuzzo; L O Carreras
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 8.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

9.  Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Authors:  Jakub Swadzba; Teresa Iwaniec; Jacek Musial
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

Review 10.  The enigmas of the lupus anticoagulant: mechanisms, diagnosis, and management.

Authors:  Richard A Marlar; Sanam Husain
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.